Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver

Mechanisms of checkpoint inhibition‐induced adverse events

(2020) P. Urwyler et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Top 10 Challenges in Cancer Immunotherapy

(2020) Priti S. Hegde et al.   IMMUNITY

Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis

(2020) Xuewen Wang et al.   Frontiers in Pharmacology

Engineered PD‐L1‐Expressing Platelets Reverse New‐Onset Type 1 Diabetes

(2020) Xudong Zhang et al.   ADVANCED MATERIALS

The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study

(2020) Jean-Marie Michot et al.   EUROPEAN JOURNAL OF CANCER

Moving towards personalized treatments of immune-related adverse events

(2020) Khashayar Esfahani et al.   Nature Reviews Clinical Oncology

Immune-related adverse events of checkpoint inhibitors

(2020) Manuel Ramos-Casals et al.   Nature Reviews Disease Primers

The dose threshold for nanoparticle tumour delivery

(2020) Ben Ouyang et al.   NATURE MATERIALS

Spectrum and impact of checkpoint inhibitor-induced irAEs

(2020) Laura C. Cappelli et al.   Nature Reviews Rheumatology

Liver damage related to immune checkpoint inhibitors

(2019) Naoshi Nishida et al.   Hepatology International

Biomimetic Nanotechnology toward Personalized Vaccines

(2019) Jiarong Zhou et al.   ADVANCED MATERIALS

Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities

(2019) Kristen E. Pauken et al.   TRENDS IN IMMUNOLOGY

Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects

(2019) Andrea Lombardi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

(2019) Xiao Han et al.   Science Advances

Chronic inflammation in the etiology of disease across the life span

(2019) David Furman et al.   NATURE MEDICINE

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

(2018) Javid J Moslehi et al.   LANCET

Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management

(2018) Mark A. Samaan et al.   Nature Reviews Gastroenterology & Hepatology

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

(2018) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer immunotherapy using checkpoint blockade

(2018) Antoni Ribas et al.   SCIENCE

Cytokines in clinical cancer immunotherapy

(2018) Pedro Berraondo et al.   BRITISH JOURNAL OF CANCER

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

(2018) Miguel F. Sanmamed et al.   CELL

Therapeutic T cell engineering

(2017) Michel Sadelain et al.   NATURE

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

(2017) Moufida Ben Nasr et al.   Science Translational Medicine

Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression

(2017) Hyun Seung Yoo et al.   Cell Death & Disease

Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles

(2016) Hua He et al.   ACS Nano

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

(2016) J.M. Michot et al.   EUROPEAN JOURNAL OF CANCER

Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial

(2016) Ki Tae Suk et al.   HEPATOLOGY

Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination

(2016) Yi-Nan Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

(2016) Celine Boutros et al.   Nature Reviews Clinical Oncology

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

(2016) Weiping Zou et al.   Science Translational Medicine

Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression

(2016) Lindsay C. Davies et al.   STEM CELLS

Unbalanced Immune System: Immunodeficiencies and Autoimmunity

(2016) Giuliana Giardino et al.   Frontiers in Pediatrics

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors

(2016) Claire F. Friedman et al.   JAMA Oncology

The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine

(2013) Paolo Bianco et al.   NATURE MEDICINE

Visualizing Dynamics of Sub-Hepatic Distribution of Nanoparticles Using Intravital Multiphoton Fluorescence Microscopy

(2012) Shih-Hsun Cheng et al.   ACS Nano

Mesenchymal Stromal Cells: New Directions

(2012) Armand Keating   Cell Stem Cell

A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow

(2009) Masoud Soleimani et al.   Nature Protocols

Regulatory T Cells and Inflammation: Better Late Than Never

(2008) Steven F. Ziegler   IMMUNITY